v3.26.3
Segment Information (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Segment Information    
Schedule of significant expense categories

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

​

​

June 30, 

​

June 30, 

(in thousands)

​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development expenses

​

​

​

​

​

​

​

​

​

​

​

​

Employee costs

​

$

1,536

​

$

2,341

​

$

3,575

​

$

5,271

Clinical product candidates

​

​

4,250

​

​

2,569

​

​

7,290

​

​

5,604

Nonclinical product candidates

​

​

746

​

​

981

​

​

1,604

​

​

1,646

Depreciation and amortization

​

​

265

​

​

618

​

​

541

​

​

1,254

Other R&D(1)

​

​

628

​

​

17,582

​

​

1,249

​

​

18,212

Total R&D

​

$

7,425

​

$

24,091

​

$

14,259

​

$

31,987

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

General and administrative expenses

​

​

​

​

​

​

​

​

​

​

​

​

Employee costs

​

$

877

​

$

1,374

​

$

2,400

​

$

3,451

Professional services

​

​

1,160

​

​

1,266

​

​

2,273

​

​

2,346

Insurance

​

​

233

​

​

243

​

​

455

​

​

505

Other G&A(2)

​

​

322

​

​

318

​

​

735

​

​

625

Total G&A

​

$

2,592

​

$

3,201

​

$

5,863

​

$

6,927

(1)Other R&D consists of facilities related expenses and office expenses and includes $17 million related to the License Agreement with Zaiming for both the three and six months ended June 30, 2025 (Note 3).
(2)Other G&A consists of facilities related expenses, depreciation, office expenses and taxes and fees.

The tables below summarize the significant expense categories regularly reviewed by the CODM for the years ended December 31, 2025 and 2024:

​

​

​

​

​

​

​

​

​

​

Year Ended

​

​

December 31, 

(in thousands)

​

2025

  ​ ​ ​

​

2024

Research and development expenses

​

​

​

​

​

​

Employee costs

​

$

8,974

​

$

13,252

Clinical product candidates

​

​

27,669

​

​

13,562

Nonclinical product candidates

​

​

3,758

​

​

9,182

Depreciation and amortization

​

​

2,133

​

​

2,792

Other R&D(1)

​

​

2,389

​

​

2,700

Total R&D

​

$

44,923

​

$

41,488

​

​

​

​

​

​

​

​

​

​

​

​

​

​

General and administrative expenses

​

​

​

​

​

​

Employee costs

​

$

5,887

​

$

8,400

Professional services

​

​

4,614

​

​

4,449

Insurance

​

​

947

​

​

1,281

Other G&A(2)

​

​

1,245

​

​

1,588

Total G&A

​

$

12,693

​

$

15,718

(1)Other R&D consists of facilities related expenses and office expenses.

(2)Other G&A consists of facilities related expenses, depreciation, office expenses and taxes and fees.

​